Childhood Cancer Research

You are here

Children’s Hospital of Philadelphia

3401 Civic Center Boulevard
Philadelphia, PA 19104
United States

Background


Cancers arise because of mutations (or mistakes) in their genes. For many cancers, the identification of their most important cancer genes, and an improved understanding of how these effect the cancer cells, has led to new treatments. Neuroblastoma is a childhood tumor that is often difficult to cure.

Developing new therapies for infants, children, adolescents and young adults with cancer requires a well-trained, dedicated multidisciplinary team. Physicians and scientists at The Children's Hospital of Philadelphia Division of Oncology and Center for Childhood Cancer Research are collaborating to develop new therapies for cancer. We are dedicated to improving our understanding of the biology and genomics of childhood cancer, developing better preclinical models, evaluating new drugs, and improving the efficiency and conduct of clinical trials.

Background


Despite the fact that cooperative group oncology trials have improved overall survival for children with cancer, investigators face significant challenges in conducting trials. This application seeks to develop novel data sets to improve the effectiveness of cooperative use trials by using administrative clinical data from approximately 100 hospital sites. Administrative clinical data contains an enormous wealth of information and its value has only recently begun to be realized in health-based research.

Dr. Schnepp has joined the Department of Pediatrics at Emory University and is a member of the Aflac Cancer and Blood Disorders Center in Atlanta, GA.

Pages